RAN is a protein regulating the rate of nucleocytoplasmic shuttling, and cancer possessing KRAS activating mutation, c-Met enhancement, and PTEN-deletion are more sensitive to apoptosis induced by silencing RAN [32,33]. The gene discussed is MET; the disease is cancer.